谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aimm) Study

Richard B. Warren,Lev Pavlovsky,Antonio Costanzo,Michael Bukhalo,Neil J. Korman,Yu-Huei Huang,Georgios Kokolakis,Andreas Pinter,Nadia Ibrahim, Yanbing Zheng,Leonidas Drogaris,Vassilis Stakias,Ahmed M. Soliman,Simone Rubant,Diamant Thaçi

Dermatology and Therapy（2025）

引用 0|浏览2
关键词
Psoriasis,Efficacy,Safety,Risankizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要